Author name: Sarah McCall

A Deliciously Easy Way to Fundraise for Cure SMA

Nothing brings people together more than sharing a meal, but what if you could make that meal even more meaningful? We’re encouraging all members of our SMA community to consider hosting a dining fundraiser, where a portion of purchases are designated to support Cure SMA. This is also a great way to supplement your efforts […]

A Deliciously Easy Way to Fundraise for Cure SMA Read More »

Special NBS Awareness Month Announcement: South Carolina Screens for SMA!

Cure SMA is pleased to announce that South Carolina is now screening babies born in the state for spinal muscular atrophy (SMA). South Carolina Department of Health and Environmental Control (DHEC) officials shared the exciting news with Cure SMA in a written statement earlier today: Good news! The new multiplex PCR based method for screening

Special NBS Awareness Month Announcement: South Carolina Screens for SMA! Read More »

Kids: We Invite You to Bake a Difference for Cure SMA!

Cure SMA is calling all future bakers and pastry chefs to help us bake a difference for individuals with spinal muscular atrophy (SMA). Baking a Difference was created by kids for kids with sweet hearts and a love of sweet treats. From a red wagon selling treats outside a local grocery store to full-fledged enterprise

Kids: We Invite You to Bake a Difference for Cure SMA! Read More »

Seat Elevators on Power Wheelchairs are a Necessity, not a Luxury, according to the SMA Community

Individuals with spinal muscular atrophy (SMA) who utilize power wheelchairs for their mobility agree that seat elevation, which allows an individual to adjust their wheelchair seat, helps improve mental and physical health, increase quality of life, and promote independence. The SMA community’s views were shared in a public comment letter Cure SMA sent to the

Seat Elevators on Power Wheelchairs are a Necessity, not a Luxury, according to the SMA Community Read More »

Cure SMA Launches Benefit-Risk Survey to Assess Patient Perspective on Treatment Possibilities and Risks

Cure SMA is conducting a survey to understand our community’s perspectives on treatment possibilities and tolerance for the side effects of currently available and planned therapies. The results will help inform our future objectives and priorities as well as help us continue to bring the patient voice to regulatory authorities. Some of you may recall

Cure SMA Launches Benefit-Risk Survey to Assess Patient Perspective on Treatment Possibilities and Risks Read More »

Community Statement from Novartis Gene Therapies: Zolgensma Safety Monitoring Update on Acute Liver Failure

Dear SMA Community, Novartis Gene Therapies is committed to patient safety and the ongoing monitoring of adverse events as it relates to the use of Zolgensma® (onasemnogene abeparvovec-xioi), the one-time gene therapy for spinal muscular atrophy (SMA). We are writing to share that there have recently been two patient fatalities related to acute liver failure

Community Statement from Novartis Gene Therapies: Zolgensma Safety Monitoring Update on Acute Liver Failure Read More »

FDA Issues Safety Warning Regarding Neck Float Devices for Babies

On June 28,2022, the U.S. Food and Drug Administration (FDA) issued a safety communication about using neck float with babies. This occurs when a serious injury has been reported while using a device or product. The FDA warns parents, caregivers, and health care providers not to use neck floats with babies for water therapy interventions,

FDA Issues Safety Warning Regarding Neck Float Devices for Babies Read More »

Scroll to Top